You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 23, 2024

ORGARAN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Orgaran, and when can generic versions of Orgaran launch?

Orgaran is a drug marketed by Aspen Global Inc and is included in one NDA.

The generic ingredient in ORGARAN is danaparoid sodium. There is one drug master file entry for this compound. Additional details are available on the danaparoid sodium profile page.

Summary for ORGARAN
US Patents:0
Applicants:1
NDAs:1
Clinical Trials: 1
Formulation / Manufacturing:see details
DailyMed Link:ORGARAN at DailyMed
Drug patent expirations by year for ORGARAN
Recent Clinical Trials for ORGARAN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Aspen Global IncorporatedPhase 3

See all ORGARAN clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for ORGARAN

US Patents and Regulatory Information for ORGARAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aspen Global Inc ORGARAN danaparoid sodium INJECTABLE;INJECTION 020430-001 Dec 24, 1996 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for ORGARAN

See the table below for patents covering ORGARAN around the world.

Country Patent Number Title Estimated Expiration
New Zealand 235440 SULPHATED GLYCOSAMINOGLYCURONAN WITH ANTITHROMBOTIC ACTIVITY, PROCESS FOR PREPARING IT AND PHARMACEUTICAL COMPOSITIONS ⤷  Try a Trial
Ireland 64121 Sulphated glycosaminoglycuronan with antithrombotic activity ⤷  Try a Trial
Denmark 0421508 ⤷  Try a Trial
Finland 101152 ⤷  Try a Trial
European Patent Office 0421508 Glycosaminoglycuronane sulphoné à activité antithrombotique. (Sulphated glycosaminoglycuronan with antithrombotic activity.) ⤷  Try a Trial
Portugal 95511 PROCESSO DE PRODUCAO DE GLICOSAMINOGLICURONANO SULFATO E DE COMPOSICOES FARMACEUTICAS ⤷  Try a Trial
Austria 98656 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.